Literature DB >> 7633412

Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy.

N R Rodrigues1, N Owen, K Talbot, J Ignatius, V Dubowitz, K E Davies.   

Abstract

Autosomal recessive spinal muscular atrophy is a motor neuron disease which affects about 1 in 10,000 births. Recent evidence shows that the candidate region contains multiple copies of genes and pseudogenes and is characterised by genome instability. We have analysed the frequency of deletions in a recently characterised candidate survival motor neuron (SMN) gene. Our data confirm previous analyses and show that this gene is disrupted by deletion in SMA patients. The same deletion frequency is observed in the milder variants of the disease as in patients with the severe form. In addition, we observed one case of a new mutation in a family previously thought not to be segregating for a chromosome 5 linked form of SMA. This assay is a very good diagnostic for SMA although no direct correlation between phenotype and genotype is apparent and carrier status cannot be determined. The implications for the identification of the gene or genes causing the disease are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7633412     DOI: 10.1093/hmg/4.4.631

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

Authors:  B Schrank; R Götz; J M Gunnersen; J M Ure; K V Toyka; A G Smith; M Sendtner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

3.  De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.

Authors:  B Wirth; T Schmidt; E Hahnen; S Rudnik-Schöneborn; M Krawczak; B Müller-Myhsok; J Schönling; K Zerres
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease.

Authors:  E Hahnen; J Schönling; S Rudnik-Schöneborn; K Zerres; B Wirth
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 5.  Molecular genetics of autosomal recessive spinal muscular atrophy.

Authors:  N R Rodrigues; K Talbot; K E Davies
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

6.  Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family.

Authors:  L Campbell; R J Daniels; V Dubowitz; K E Davies
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

7.  Balanced translocation t(4q; 10q) in infantile spinal muscular atrophy.

Authors:  G Hofner; L Nährlich; H Lauffer
Journal:  Eur J Pediatr       Date:  1997-11       Impact factor: 3.183

8.  Gene deletions in spinal muscular atrophy.

Authors:  N R Rodrigues; N Owen; K Talbot; S Patel; F Muntoni; J Ignatius; V Dubowitz; K E Davies
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

9.  SMN gene analysis of the spinal form of Charcot-Marie-Tooth disease.

Authors:  A Hanash; E Leguern; N Birouk; O Clermont; J Pouget; P Bouche; A Munnich; A Brice; J Melki
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

10.  Molecular diagnosis of spinal muscular atrophy.

Authors:  H Stewart; A Wallace; J McGaughran; R Mountford; H Kingston
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.